Dr. Penza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
1st Floor
Columbus, OH 43210Phone+1 614-293-3316Fax+1 614-293-6050- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995
- Ohio State University HospitalResidency, Internal Medicine, 1989 - 1992
- Ohio State University College of MedicineClass of 1989
Certifications & Licensure
- OH State Medical License 1991 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
Publications & Presentations
PubMed
- Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.Thomas Spitzer, Monzr M Al Malki, James Mason, Chelsa Tourville, Brandon Magliocco, Jacklyn Barten, Hope Guidry-Groves, Jamie Margolis, Steven M Devine, Heather E Stef...> ;Transplantation and Cellular Therapy. 2024 Apr 18
- Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease.Rohan Mital, Sam L Penza, Hannah K Choe, Catherine G Chung, Benjamin H Kaffenberger> ;Journal of the European Academy of Dermatology and Venereology. 2023 Nov 1
- Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang, Abdullah Khan, David Bond, Yazeed Sawalha, John Reneau, Lapo Alinari, Robert Baiocchi, Beth...> ;Cancer Medicine. 2023 Apr 1
- Join now to see all
Abstracts/Posters
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationSam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki...Sam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Member
Hospital Affiliations
- Ohio State University Wexner Medical CenterColumbus, Ohio
- The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: